Awards & Funding

Awarded Grants:

  • Jun 16, 2015 – CIHR grant under the competition entitled “Partnerships for Health System Improvements” (PHSI) – 3 year term
    • Applying syndemic/core group theory to improve integrated prevention and service delivery for HIV and related epidemics.
    • PI – Dr Naveed Janjua; Co-Investigators – Dr Mel Krajden, Dr Jason Wong, Dr. Mark Gilbert
  • Aug 4, 2015 – CIHR Team Grant – 5 year term
    • The National CIHR Hepatitis C Network (NCHCN)/ Canadian Hepatitis C Network
    • PI – Dr Mel Krajden; Co-Investigators – Dr Naveed Janjua, Dr Mark Tyndall
  • May 24, 2016, Opioid Prescribing Evaluation and Research Activities
    • BCCDC Foundation Blue Sky Award
    • PIs- Dr. Roy Purssell, Dr Jane Buxton, Dr  Naveed Janjua
  • July 2017, Michael Smith Foundation for Health Research- Post Doctoral Fellowship Award
      • Advent of highly effective direct acting antiviral(DAA) therapies for treatment of hepatitis C virus (HCV) has been a major medical breakthrough. However, data on their real-world impact on health of people affected by HCV is lacking. Dr. Maryam Darvishian, postdoctoral fellow at UBC and BCCDC, received Micheal Smith Foundation for Health Research (MFSHR) trainig award to examine the real-world effectiveness of hepatitis C treatments in serious liver-related illnesses such as hospitalization, decompensated cirrhosis and liver cancer. Read More Here
      • Awarded to Dr. Maryam Darvishian

Recognition:

  • CROI Young Investigators Scholarship 2017
    • Butt ZA, Shrestha N, Janjua NZ, Gesink D, Gilbert M, Wong J, Kuo M, Yu A, Alvarez, Chong M, Samji H, Buxton J, Roth D, Consolacion T, Murti M, Ogilvie G, Balshaw T, Tyndall M, Krajden M. Effect of OST and Psychotherapy on HIV Risk among HCV Infected Individuals [abstract]. In: Conference on Retrovirus and Opportunistic Infections: 2017 Feb 13-16, Seattle, WA. Abstract nr 511
    • Awarded to Dr. Zahid Butt
  • CIHR Health Systems Impact Fellowship
    • Awarded to Nazrul Islam